Our general counsel, Derek Johnson, recently passed the one-year mark at Portal. Maybe one day he’ll get a permanent nameplate. Unfortunately today is not that day - sorry Derek.
Portal Innovations, LLC
Biotechnology Research
Chicago, Illinois 11,122 followers
Portal Innovations fuels life science breakthroughs with human, financial, and physical capital.
About us
Portal Innovations is a premier venture development engine that bridges scientific ideation in life sciences, medtech, and bioinformatics through commercial proof of concept by delivering seed capital, specialized equipment, lab space, and management expertise to high-potential early stage companies.
- Website
-
http://www.portalinno.com
External link for Portal Innovations, LLC
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Chicago, Illinois
- Type
- Privately Held
- Founded
- 2020
- Specialties
- biotech, pharma, biopharma, medtech, healthtech, life sciences, data sciences, pharmaceuticals, medical devices, innovation, and pharma strategy
Locations
-
Primary
1375 W Fulton Ave
Chicago, Illinois 60607, US
-
Atlanta, Georgia, US
-
135 William T Morrissey Blvd
Boston, Massachusetts 02125, US
-
Houston, TX, US
Employees at Portal Innovations, LLC
Updates
-
Portal Innovations, LLC reposted this
We are 1 week away from our Annual Fund Update in advance of the National Bleeding Disorders Foundation Bleeding Disorders Conference in Atlanta, Georgia. You won't want to miss this opportunity to see the 10th floor at the new Portal Innovations, LLC lab incubator. Please RSVP by this Friday, September 6th by emailing Renee Peck at [email protected] We are excited to partner with Portal Innovations, LLC at their Science Square labs as we share how our investments in emerging biotech companies are progressing towards our vision of a world without inheritable blood and bleeding disorders. We are grateful for the generous support of this event from Merz Branding and Portal Innovations, LLC. Come join us for breakfast and learn about the innovative research we are currently investing in with Anvesana, Spark Biomedical Inc, and Afimmune Ltd and our upcoming investments. #innovation #bleedingdisorders #venturephilanthropy #blooddisorders
-
-
Time is running out to register for our Portal Primer event with The University of Texas Medical Branch! On September 12th we're offering an informational program for UTMB faculty and students interested in commercializing their scientific research. The session will cover the various risks that technologies face as they transition from the bench to the marketplace. Learn more and register below! https://lnkd.in/ghNwaKht
-
-
Welcome to Portal Houston, Michael Torres and the CrossBridge Bio team!
The equivalent of commenting first! Great to be here and get our offices set up! Exciting to see #Texas continue building out the ecosystem. I’m especially excited to have CrossBridge Bio based here at Texas Medical Center!
-
-
Another Atlanta Portal Pours is in the books! Thanks to everyone who attended last week's event alongside University Bioconnect that helped university students learn more about careers in life sciences! We hope everyone enjoyed the event, and be sure to register to attend our Atlanta grand opening on September 24th! https://lnkd.in/gWPys4NZ
-
-
We're hiring Lab Operations Associates in Houston AND Atlanta! Know anyone who might be a fit? Take a look at the job descriptions and apply below! Atlanta job posting: https://lnkd.in/g66CygZF Houston job posting: https://lnkd.in/gmXcv5Ku
-
Here's a fantastic piece in the Chicago Business Journal that discusses how nearby universities are fueling the city's tech scene. Thanks to Alex Zorn for mentioning Portal in the article - we're excited that our Powered by Portal model is already being implemented to help the University of Chicago, and we're looking forward to working with other universities across the U.S. to accelerate their startups! https://lnkd.in/gcYDn-dG
-
While we're not prepared to officially say goodbye to summer, thanks to everyone in Boston who showed up to our end-of-summer happy hour at Southline! This event gave everyone a great opportunity to network with others in our life sciences ecosystem. A big thanks to ClinLab Staffing for sponsoring this event!
-
-
Welcome our newest venture fellows to Portal Innovations! Karis D'Alessandro, Liisa Parts, Gandhar D., and Hyoann Choi are joining Portal to help run due diligence on a variety of potential life sciences startup investments. Learn more about our fellows below. Karis D'Alessandro is a PhD student at Northwestern University studying mitochondrial dysfunction in Parkinson's disease. Before starting her PhD, Karis graduated with a BS in Neuroscience from The Johns Hopkins University. She looks forward to leveraging her scientific knowledge to support groundbreaking startups in emerging biotech ecosystems while at Portal. Liisa is a second year MBA student at The University of Chicago Booth School of Business. She brings to the Venture Fellow role prior experience as an Associate at the Polsky Center George Schulz Innovation Fund. Liisa worked in life sciences strategy consulting at L.E.K. for more than 3 years, focusing on due diligence and strategy work across the life sciences industry in Europe and US. Prior to this, she completed a PhD in Interdisciplinary Bioscience at the University of Oxford using the wonderful worms (C. elegans) to study the natural prevalence, evolution, and molecular mechanisms of pesticide resistance. Liisa enjoys supporting the Chicago early-stage science ecosystem and worked with several local Portal-based life sciences startups over the summer as a part of an internship with Portal’s Ex3 program. Gandhar Datar is a 7th year MD/PhD student at Baylor College of Medicine where his research focuses on the biophysical mechanisms underlying leukemia development. He was awarded an NIH F30 pre-doctoral Fellowship from the National Cancer Institute (NCI) and has prior experience in business development and operations as a Therapeutics Intern at Fannin. Gandhar graduated with a B.S. in Molecular & Cellular Biology from the University of Illinois Urbana-Champaign. Hyoann Choi is a 4th year PhD student in Biological Engineering at Georgia Institute of Technology specializing in point-of-care diagnostic development and biomedical data analytics using ML and AI. Besides her PhD work, Hyoann develops business strategies for startups and perform due diligence for venture investments. Hyoann is building her career in both venture creation and investing, with a particular interest in life science and healthcare industry. Hyoann graduated with her Bachelor’s in Biological Engineering at Cornell University. Welcome aboard!
-